STAT

Opinion: For medicine regulators, reliance is a global imperative

A new report from the U.S. National Academies, "Regulating Medicines in a Globalized World," shows how regulatory authorities can work together and avoid duplication.

It’s never been more challenging to make sure that medicines meet standards for quality, safety, and effectiveness. Rapidly evolving technologies, advances in medical therapies, and increasingly complex supply chains are stressing medicine regulators around the globe.

Great gains can be made when countries’ medicine regulators work together and share resources to ensure that their citizens have timely access to high-quality, safe, and effective medicines — an important role of government and an essential public health function.

Regulatory authorities that share information or that rely on each other’s work have expedited the approval of essential vaccines and medicines, prevented the distribution of substandard and fake medicines, and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks